Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06585774 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Study acronym: AXemplify-357
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 61 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 128 → 131 locations
  2. Study sites: 126 to 128
  3. Study sites: 125 to 126v59
  4. Study sites: 123 to 125v58
  5. Study sites: 122 to 123v57
  6. Site details revised at 1 of 122 sitesv56
  7. Trial sites expanded: 119 → 122 locationsv55
  8. Site details revised at 1 of 119 sitesv54
  9. Study sites: 118 to 119v53
  10. Trial sites expanded: 115 → 118 locationsv52
  11. Study sites: 113 to 115v51
  12. Site details revised at 2 of 113 sitesv50
  13. Site details revised at 1 of 113 sitesv49
  14. Re-verified, no change to tracked fieldsv48
  15. Study sites: 112 to 113v47
  16. Re-verified, no change to tracked fieldsv46
  17. Study sites: 111 to 112v45
  18. Study sites: 110 to 111v44
  19. Study sites: 109 to 110v43
  20. Site details revised at 6 of 109 sitesv42
  21. Study sites: 106 to 109v41
  22. Study sites: 99 to 106v40
  23. Study sites: 97 to 99v39
  24. Study sites: 95 to 97v38
  25. Study sites: 93 to 95v37
  26. Re-verified, no change to tracked fieldsv36
  27. Study sites: 92 to 93v35
  28. Study sites: 90 to 92v34
  29. Study sites: 89 to 90v33
  30. Study sites: 88 to 89v32
  31. Study sites: 86 to 88v31
  32. Study sites: 84 to 86v30
  33. Study sites: 82 to 84v29
  34. Study sites: 80 to 82v28
  35. Study sites: 75 to 80v27
  36. Study sites: 73 to 75v26
  37. Study sites: 68 to 73v25
  38. Study sites: 66 to 68v24
  39. Study sites: 63 to 66v23
  40. Study sites: 59 to 63v22
  41. Study sites: 55 to 59v21
  42. Study sites: 52 to 55v20
  43. Study sites: 48 to 52v19
  44. Study sites: 46 to 48v18
  45. Study sites: 44 to 46v17
  46. Study sites: 42 to 44v16
  47. Study sites: 30 to 42v15
  48. Study sites: 26 to 30v14
  49. Study sites: 19 to 26v13
  50. Study sites: 16 to 19v12
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Incyte
94 trials monitored
See 9 trials at risk
This study will be conducted to compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
Trial Details
NCT Number NCT06585774
Lead Sponsor Incyte Corporation
Conditions Chronic Graft-versus-host-disease
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov